Sheikh Shakhbout performs the UAE’s first robotic thyroid surgery
Category: HealthTech
By Irfan
Published: 2026-10-20T08:28:00.000Z
Doctors at Sheikh Shakhbout Medical City in Abu Dhabi performed the UAE’s first robotic thyroid surgery on a 27-year-old woman. She was discharged the next day. The approach uses armpit incisions and avoids a neck scar.
Doctors at Sheikh Shakhbout Medical City in Abu Dhabi have performed the UAE’s first robotic thyroid surgery. The patient was a 27-year-old woman with a 3 cm nodule on the left side of her thyroid. She had swelling that made swallowing difficult and caused a choking sensation while sleeping. The team used small incisions in both armpits. The operation took about one hour. She was discharged the next day. No long-term outcome data, no cost and no comparison with conventional thyroidectomy rates were published. Traditional thyroid surgery uses an incision at the front of the neck and leaves a visible scar. The robotic approach reaches the gland through the armpits and avoids that scar. The technique is already used in other countries. This is the first time it has been done in the UAE. Sheikh Shakhbout Medical City, a PureHealth subsidiary, has run a robotic surgery program since 2020. It has completed more than 1,260 robotic-assisted procedures across thoracic surgery, urology, oncology, orthopaedics, neurosurgery and general surgery. Volumes rose 42 percent in the first half of 2026. The hospital now performs more than 500 robotic cases a year. For a woman in Abu Dhabi or Dubai who needs a thyroid nodule removed the useful distinction is between a local option and a trip abroad. Before this case an eligible patient who wanted the armpit approach had to travel. She can now be assessed at Sheikh Shakhbout. Eligibility still depends on the size and location of the nodule and on the surgeon’s judgement. The release does not say how many patients in the UAE would meet those criteria, or how many have already been referred. The short stay is the other reported result. Discharge the day after a one-hour operation is consistent with the reduced tissue trauma claimed for the robotic route. It is one case. A single discharge does not establish a new average length of stay for the procedure in the UAE. The hospital has not published a series or a complication rate for robotic thyroidectomy. It has published the total robotic volume across all specialties. Surgeons involved included Dr Abdulqader Almessabi and Salem Alharthi. They noted that thyroid surgery requires care around the surrounding nerves and glands, and that the robotic option gives eligible patients an additional choice closer to home. Those are clinical statements. They are not outcome statistics. Other Gulf hospitals are expanding robotic capacity. A center in Riyadh or Doha that already has a robotic platform can add thyroid cases once its surgeons are trained. The training and the case selection take time. The Abu Dhabi case shows the procedure can be done locally. It does not show how many centers will offer it next year. A further limit is the patient selection. A 3 cm nodule with abnormal features in a young woman is one indication. Larger goiters, cancer cases or patients with prior neck surgery may not be suitable for the armpit route. The release does not list the exclusion criteria. A referring doctor in Sharjah or Al Ain still has to confirm that a given patient fits. The hospital’s broader robotic numbers show demand. More than 1,260 cases since 2020 and a 42 percent rise in the first half of 2026 indicate that patients and surgeons are using the platforms. Thyroid is a new addition to that list. Whether it becomes a regular service depends on how many suitable patients present and how the first series performs. That series has not been published. Cost is another unpublished figure. Robotic platforms are expensive to buy and to maintain. A patient who previously travelled for the scar less approach may now pay a local fee. The release does not say whether that fee is higher, lower or the same as a conventional thyroidectomy at the same hospital. Until the price is known, the access claim is clinical, not financial. If Sheikh Shakhbout publishes the number of robotic thyroid cases performed in the next twelve months and their complication and length-of-stay figures, the first case has a follow-on record. If the next line is only another single-case announcement, count the patients who stayed one day and the patients who needed a conventional incision instead. The figure missing is both.